Theseus Pharmaceuticals (NASDAQ:THRX) reported quarterly losses of $(0.30) per share. This is a 95.6 percent increase over losses of $(6.82) per share from the same period last year.
Navitas Highlights EV High-speed Hybrid Power Semiconductor Advances In China Innovation Summit Keynote
Navitas Semiconductor (NASDAQ:NVTS), the industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors, today announced its participation in